The medical device company experienced a huge growth in revenue in FY20. Atomo Diagnostics Ltd’s [ASX:AT1] boost is primarily driven by the acceleration of HIV rollout via Mylan. This saw the AT1 share price move up 3.03% to 34 cents at the time of writing...
